Steve Aselage - Oct 7, 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Oct 7, 2021
Transactions value $
-$600,960
Form type
4
Date filed
10/8/2021, 04:18 PM
Previous filing
Sep 2, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Options Exercise $974K +60K +31.61% $16.23 250K Oct 7, 2021 Direct
transaction TVTX Common Stock Sale -$734K -28K -11.21% $26.23 222K Oct 7, 2021 Direct F1
transaction TVTX Common Stock Sale -$840K -32K -14.43% $26.26 190K Oct 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -60K -42.86% $0.00 80K Oct 7, 2021 Common Stock 60K $16.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 The stock option is fully vested and exercisable.